José Luis Cabero

José Luis Cabero is an accomplished professional in the life sciences and biotechnology sectors, currently serving as a Member of the Scientific Advisory Board at Bionova Capital since June 2021. Cabero has extensive experience as a consultant for Symbiokraft and as a member of the Expert Panel and Mentor for CaixaImpulse/CaixaResearch Validate & Consolidate, both focused on supporting entrepreneurship and the development of innovations in health and life sciences. Previously, Cabero held leadership roles including Chief Executive Officer at AELIX Therapeutics and ALGENEX S.L., and Interim Chief Executive Officer at Laboratorios LETI S.L., driving advancements in therapeutic vaccines and biotechnology. Early career experiences at AstraZeneca R&D involved significant contributions to research strategies and portfolio management in the cardiovascular and gastrointestinal fields. Cabero holds an Advanced Management Programme certificate from Harvard Business School, a Doctor of Medical Science degree from Uppsala University, and a Licenciate in Biological Sciences from Mar del Plata National University in Argentina.